ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

XGN Exagen Inc

1.40
0.015 (1.08%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Exagen Inc XGN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.015 1.08% 1.40 09:00:00
始値 安値 高値 終値 前日終値
1.38 1.3606 1.42 1.40 1.385
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0105:05GLOBEExagen to Announce First Quarter 2024 Results on May 13,..
2024/4/2621:30GLOBEExagen Inc. Announces Changes to the Board of Directors
2024/3/1821:00GLOBEExagen Inc. Reports Strong Fourth Quarter and Full-Year 2023..
2024/3/1820:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
2024/3/0823:00GLOBEExagen Inc. to Participate in the KeyBanc Capital..
2024/3/0806:05GLOBEExagen to Announce Fourth Quarter 2023 and Full-Year..
2024/3/0706:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2306:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1421:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0906:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0305:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/3106:05GLOBEExagen Inc. to Participate in the 2024 BTIG MedTech, Digital..
2024/1/2306:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0822:00EDGAR2Form 8-K - Current report
2024/1/0802:00GLOBEExagen Inc. Announces Select Preliminary Full-Year 2023..
2023/12/1206:05EDGAR2Form 8-K - Current report
2023/11/3014:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/3007:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/2806:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
2023/11/2022:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/1806:30EDGAR2Form 8-K - Current report
2023/11/1806:06EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1407:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:05EDGAR2Form 8-K - Current report
2023/11/1406:05GLOBEExagen Inc. Reports Strong Third Quarter 2023 Results
2023/11/1006:05GLOBEExagen Inc. and Johns Hopkins University Announce License..
2023/11/0305:05GLOBEExagen Inc. to Participate in the 2023 Canaccord Genuity..
2023/10/3105:05GLOBEExagen to Announce Third Quarter 2023 Financial Results on..
2023/10/1905:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1803:50DJNExagen Agrees to Pay Over $650K to Resolve Kickback..
2023/9/2905:05GLOBEExagen Announces Acceptance of Multiple Abstracts at ACR..
2023/9/1305:05GLOBEExagen Inc. to Participate in the 2023 Cantor Fitzgerald..
2023/9/0706:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0722:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0721:00EDGAR2Form 8-K - Current report
2023/8/0721:00GLOBEExagen Inc. Reports Strong Second Quarter 2023 Results
2023/7/2705:05GLOBEExagen Inc. to Participate in the Canaccord Genuity 43rd..
2023/7/2605:05GLOBEExagen to Announce Second Quarter 2023 Financial Results on..
2023/7/2505:05EDGAR2Form 8-K - Current report
2023/7/2505:05GLOBEExagen Inc. Appoints Paul Kim to Board of Directors
2023/5/3022:00GLOBEExagen Inc. to Participate in the William Blair 43rd Annual..
2023/5/1605:05GLOBEExagen Inc. Reports First Quarter 2023 Results

最近閲覧した銘柄

Delayed Upgrade Clock